Neuroscience 156 , 165174 (2008)
The first pathway involves the downstream consequences of elevated GH and IGF-1
In fact, research published in Diabetes, Obesity, and Metabolism found that participants regained two-thirds of the weight they had previously lost after they stopped using Wegovy
Studies have shown that patients on these medications, combined with lifestyle changes, can achieve substantial weight loss, often in the range of 15% to over 20% of their total body weight, making them a powerful tool in the fight against obesity
Full text: Labarrere, C
And these smaller molecules can trigger the release of not only GLP-1, but also another key hormone that decreases your appetite, called PYY (peptide YY)